Clindamycin bioadhesive cream - AMAG Pharmaceuticals

Drug Profile

Clindamycin bioadhesive cream - AMAG Pharmaceuticals

Alternative Names: Clindesse

Latest Information Update: 13 Nov 2014

Price : $50

At a glance

  • Originator KV Pharmaceutical Company
  • Developer Lumara Health
  • Class Antibacterials; Lincosamides; Small molecules
  • Mechanism of Action Protein 50S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Bacterial vaginosis

Most Recent Events

  • 12 Nov 2014 Lumara Health has been acquired by AMAG Pharmaceuticals
  • 29 May 2014 KV Pharmaceutical is now called Lumara Health
  • 05 Aug 2013 Launched for Bacterial vaginosis (in non-pregnant women) in USA (Vaginal, 2% cream, single dose)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top